First Tx for Erdheim-Chester Disease, a Rare Blood Cancer First Tx for Erdheim-Chester Disease, a Rare Blood Cancer

The first FDA-approved treatment for Erdheim-Chester dDisease (ECD), a rare blood cancer, is vemurafenib, a targeted therapy already used in melanoma with BRAF V600E mutations.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news